The legal class B infectious disease - the 2019 novel coronavirus (2019-nCoV) infected pneumonia in Wuhan, China: a review
On January 20, 2020, the National Health Commission of the People's Republic of China issued the No. 1 document of 2020, which officially incorporated the 2019 novel coronavirus (2019-nCoV) infected pneumonia into the Class B infectious diseases specified in the Law of the People's R...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Office of New Medicine
2020-02-01
|
| Series: | Yixue xinzhi zazhi |
| Subjects: | |
| Online Access: | https://yxxz.whuznhmedj.com/storage/attach/2002/r4BkY2nds9VK99WaIhRfBDdt3yZB3QwKp7WsFpko.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | On January 20, 2020, the National Health Commission of the People's Republic of China issued the No. 1 document of 2020, which officially incorporated the 2019 novel coronavirus (2019-nCoV) infected pneumonia into the Class B infectious diseases specified in the Law of the People's Republic of China on the Prevention and Treatment of Infectious Diseases, and adopted the Class A infectious diseases prevention and control measures. The article summarizes the origin of 2019-nCoV infected pneumonia, related concepts, and respiratory coronavirus that often causes unexplained pneumonia. It focuses on the pathology and radiology manifestations of SARS, and the principles of management of 2019-nCoV infected pneumonia. |
|---|---|
| ISSN: | 1004-5511 |